Skip to main content

Table 1 Participant characteristics

From: Sex-specific risk factors and clinical dementia outcomes for white matter hyperintensities in a large South Korean cohort

Characteristic

Group; Mean (SD)

Statistical Test

p-value

Male, n  = 241

Female, n  = 472

t-testa/chi-squared testb

 

Age

72.3 (7.44)

72.8 (7.59)

-0.93a

0.35

Participants aged < = 65 years old (%)

49 (20.3%)

87 (18.4%)

0.26b

0.61

Years of Education

10.4 (4.74)

7.04 (4.54)

9.04a

< 0.001

BMIa

23.9 (3.03)

24.0 (3.31)

-0.41a

0.68

HbA1cb, % mmol/mol

6.12 (1.04)

5.98 (0.89)

-1.80a

0.073

log(TSH)c, mIU/L

0.51 (0.82)

0.46 (0.97)

-0.78a

0.43

log(Homocysteine)d, umol/L

2.69 (0.445)

2.50 (0.36)

-5.57a

< 0.001

Global 18 F-flutemetamol SUVRe

0.68 (0.15)

0.67 (0.15)

-0.93a

0.35

‡APOE ɛ4 positive, N (%)

80 (33.2%)

135 (28.6%)

1.39b

0.24

Hypertension, N (%)

132 (54.8%)

256 (54.2%)

0.0031b

0.96

Diabetes, N (%)

67 (27.8%)

93 (19.7%)

5.6b

0.018

Smoker, N (%)

152 (63.1%)

23 (4.9%)

288.64b

< 0.001

Cognitive Diagnosis, n (%)

1.38b

0.50

No cognitive decline

n = 5 (2.1%)

n = 5 (1.1%)

  

MCI

n = 138 (57.3%)

n = 281 (59.5%)

  

Dementia

n = 98 (40.7%)

n = 186 (39.4%)

  

Cardiovascular Risk Factors

  

Pulse Pressure, mmHg

75.8 (12.4)

76.0 (11.6)

-0.24a

0.81

Systolic Blood Pressure, mmHg

130.7 (17.3)

134.6 (19.3)

-2.71a

0.0070

Diastolic Blood Pressure, mmHg

76.0 (12.1)

76.7 (11.5)

-0.70a

0.48

LDL-C, mg/dL

92.7 (33.3)

104 (38.8)

4.10a

< 0.001

HDL-C, mg/dL, M (SD)

51.6 (14.1)

58.3 (14.8)

5.89a

< 0.001

  1. Unless otherwise indicated
  2. aBMI information is available for all males and 471 out of 472 female participants
  3. bHbA1c is available for 231 out of 241 male participants and 453 out of 472 female participants
  4. cTSH is available for all male participants and 470 out of 472 female participants
  5. dHomocysteine is available for 224 out of 241 male participants and 434 out of 472 female participants
  6. eGlobal 18 F-flutemetamol SUVR is available for 209 out of 241 male participants and 435 out of 472 female participants
  7. †WMHV expressed as log(cm3/Intracranial volume)
  8. ‡ APOE ɛ4 positive: 2/4, 3/4, 4/4
  9. BMI, Body mass index; DBP, Diastolic blood pressure; HDL-C, High-density lipoprotein cholesterol; LDL-C, Low-density lipoprotein cholesterol; SBP, Systolic blood pressure; WMHV, White matter hyperintensity volume; TSH, Thyroid-stimulating hormone; SCD, Subjective cognitive decline; MCI, Mild cognitive impairment; AD, Alzheimer’s Disease; SUVR, Standard uptake value ratio; APOE, Apolipoprotein